Beutel, Goodman & CO Ltd. Eli Lilly & CO Transaction History

Beutel, Goodman & CO Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $29.3 Million - $34.3 Million	-264,854 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $37.4 Million - $44 Million	-336,153 Reduced 55.93%	264,854 $25.7 Million
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $171 Million - $192 Million	-1,614,357 Reduced 72.87%	601,007 $5.1 Million
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $24 Million - $30 Million	-279,164 Reduced 11.19%	2,215,364 $184 Million
Q2 2018 Jul 30, 2018	BUY	$75.7 - $86.88 $24.8 Million - $28.5 Million	327,484 Added 15.11%	2,494,528 $162 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $18.4 Million - $21.8 Million	-248,556 Reduced 10.29%	2,167,044 $146 Million
Q4 2017 Jan 24, 2018	BUY	$81.94 - $87.89 $9.03 Million - $9.69 Million	110,241 Added 4.78%	2,415,600 $163 Million
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $178 Million - $197 Million	2,305,359	2,305,359 $158 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Beutel, Goodman & CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Beutel, Goodman & CO Ltd. with notifications on news.